Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2008-04-01
2008-04-01
Kennedy, Sharon (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
Reexamination Certificate
active
07351423
ABSTRACT:
This invention relates to an implant for a musculoskeletal defect having a bioactive agent having a concentration gradient.
REFERENCES:
patent: 5041138 (1991-08-01), Vacanti et al.
patent: 5133755 (1992-07-01), Brekke
patent: 5368858 (1994-11-01), Hunziker
patent: 5716404 (1998-02-01), Vacanti et al.
patent: 5843156 (1998-12-01), Slepian et al.
patent: 5853753 (1998-12-01), Maierhofer et al.
patent: 5855610 (1999-01-01), Vacanti et al.
patent: 5900433 (1999-05-01), Igo et al.
patent: 6123727 (2000-09-01), Vacanti et al.
patent: 6281015 (2001-08-01), Mooney et al.
patent: 6290729 (2001-09-01), Slepian et al.
patent: 6448054 (2002-09-01), Poznansky et al.
patent: 6454811 (2002-09-01), Sherwood et al.
patent: 6468731 (2002-10-01), Hubbell et al.
patent: 6596296 (2003-07-01), Nelson et al.
patent: 6656488 (2003-12-01), Yi et al.
patent: 6656496 (2003-12-01), Kilpadi et al.
patent: 6685957 (2004-02-01), Bezemer et al.
patent: 6852330 (2005-02-01), Bowman et al.
patent: 7115280 (2006-10-01), Hanna et al.
patent: 2002/0032488 (2002-03-01), Brekke et al.
patent: 2002/0127265 (2002-09-01), Bowman et al.
patent: 2002/0150753 (2002-10-01), Me et al.
patent: 2002/0183858 (2002-12-01), Contiliano et al.
patent: 2003/0012818 (2003-01-01), Schense et al.
patent: 2003/0017141 (2003-01-01), Poznnansky et al.
patent: 2003/0022153 (2003-01-01), Kirk et al.
patent: 2003/0022197 (2003-01-01), Kirk et al.
patent: 2003/0022269 (2003-01-01), Kirk et al.
patent: 2003/0022362 (2003-01-01), Kirk et al.
patent: 2003/0036193 (2003-02-01), Fallon et al.
patent: 2003/0045943 (2003-03-01), Brekke et al.
patent: 2003/0099762 (2003-05-01), Zhang et al.
patent: 2003/0114936 (2003-06-01), Sherwood et al.
patent: 2003/0143258 (2003-07-01), Knaack et al.
patent: 2003/0147935 (2003-08-01), Binette et al.
patent: 2003/0166833 (2003-09-01), Lutolf et al.
patent: 2003/0187232 (2003-10-01), Hubbell et al.
patent: 2003/0199440 (2003-10-01), Dack et al.
patent: 2004/0002131 (2004-01-01), Kim et al.
patent: 2004/0028739 (2004-02-01), Ripon et al.
patent: 2004/0132143 (2004-07-01), DeAngelis et al.
patent: 2004/0142411 (2004-07-01), Kirk et al.
patent: 1 090 928 (2000-09-01), None
patent: 0 794 790 (2002-04-01), None
patent: 1 264 607 (2002-12-01), None
patent: 1 098 684 (2003-08-01), None
patent: 1 346 731 (2003-09-01), None
patent: 1 407 791 (2004-04-01), None
patent: 1 416 044 (2004-06-01), None
patent: WO 95/09659 (1995-04-01), None
patent: WO 00/51538 (2000-09-01), None
patent: WO 01/38428 (2001-05-01), None
patent: WO 01/70293 (2001-09-01), None
patent: WO 01/83522 (2001-11-01), None
patent: WO 01/85845 (2001-11-01), None
patent: WO 02/15955 (2002-02-01), None
patent: WO 02/062968 (2002-08-01), None
patent: WO 02/085422 (2002-10-01), None
patent: WO 02/100426 (2002-12-01), None
patent: WO 03026674 (2003-04-01), None
patent: WO 03030956 (2003-04-01), None
patent: WO 03052091 (2003-06-01), None
patent: WO 03/070186 (2003-08-01), None
patent: WO 03/078565 (2003-09-01), None
patent: WO 03103573 (2003-12-01), None
patent: WO 04032830 (2004-04-01), None
patent: WO 04032988 (2004-04-01), None
patent: WO 2004/038367 (2004-05-01), None
patent: WO 2004/053165 (2004-06-01), None
Davisdon et al., Effect of Perfusion on the Growth of Tissue Engineered Cartilage, Orthopaedic Research Society, 1999, p. 811.
Raudenbush et al., Subchondral Thickness Does Not Vary With Cartilage Degeneration on the Metatarsal, Journal of the American Podiatric Medical Association, Mar./Apr. 2003, pp. 104-110, vol. 93, No. 2.
Glowacki et al., Perfusion Enhances Functions of Bone Marrow Stromal Cells in Three-Dimensional Culture, Cell Transplantation, 1998, pp. 319-326, vol. 7, No. 3, Elsevier Science, Inc.
Bujia et al., Engineering of Cartilage Tissue Using Bioresorbable Polymer Fleeces and Perfusion Culture, Acta Otolaryngol, 1995, pp. 301-310, vol. 115, Scandinavian University Press.
Freed et al., Cultivation of Cell-Polymer Cartilage Implants in Bioreactors, Journal of Cellular Biochemistry, 1993, pp. 257-264, vol. 51, Wiley Liss, Inc.
Levin et al., Osteoarthritis-like Disorder in Rats with vascular Deprivation—induced Necrosis of the Femoral Head, Pathology Research and Practice, 1999, pp. 637-647, vol. 195, Urban & Fischer Verlag.
Sittinger et al., Engineering of Cartilage Tissue Using Bioresorbable Polymer Carries in Perfusion Culture, Biomaterials, 1994, pp. 451-456, vol. 15, No. 6, Butterworth-Heinemann Ltd.
Honner et al., The Nutritional Pathways of Articular Cartilage, The Journal of Bone and Joint Surgery, Jun. 1974, pp. 742-748, vol. 53A, No. 4.
Lajeunesse et al., “The Role of Bone in The Treatment of Osteoarthritis”, Osteoarthritis and Cartilage, 2004, pp. 34-38, vol. 12, Elsevier Ltd.
Kapur et al., “Immobilized Concentration Gradients of Nerve Growth Factor Guide Neurite Outgrowth”, Wikey IinterScience, 2003, pp. 235-243, Wiley Periodicals.
Hypolite et al., Formation of Microscale Gradients of Protein Using Heterobifunctional Photolinkers, Bioconjungate Chem., 1997, pp. 658-663, vol. 8, American Chemical Society.
Ito et al., “Gradient Micropattern Immobilization of Heparin and Its Interaction with Cells”, Journal of Biomaterial Science Polymer Edition, 2001, pp. 367-378, vol. 12, No. 4.
Cao et al., Defining the Concentration Gradient of Nerve Growth Factor For Guided Neurite Outgrowth, Neuroscience,2001, pp. 831-840, vol. 103, No. 3, Elsevier Science Ltd.
Mahewhwari et al., “Cell Adhesion and Motility Depend on Nanoscale RGD Clustering”, Journal of Cell Science, 2000, pp. 1677-1686, vol. 113, The Company of Biologistics Limited.
Gallo et al., “The trkA Receptor Mediates Growth Cone Turning Toward A Localized Source of Nerve Growth Factor”, The Journal of Neuroscience, Jul. 15, 1997, pp. 5445-5454, vol. 14, No. 14, Society for Neruoscience.
Kuffler et al., Guidance of Regenerating Motor Axons in Vivo By Gradients of Diffusible Perpheral Nerve-Derived Factors, Journal of Neurobiology, Feb. 2000, pp. 212-219, vol. 42, No. 2.
Baier et al., “Axon Guidance by Gradients of a Target-Derived Component”, Science, Jan. 24, 1992, pp. 472-475, vol. 255, issue 5043, American Association For The Advancement of Science.
Snow et al., Neurite Outgrowth on a Step Gradient of Chondrotin Sulfate Proteoglycan (CS-PG), Journal of Neurobiology, 1992, pp. 322-336, vol. 23.
Flurkey, “An Inexpensive Gradient Make for the Biochemistry Laboratory”, Journal of Chemical Education, Aug. 2000, pp. 1041-, vol. 77, Issue 8, American Chemical Society.
Iwasaki et al., “The Effect of The Chemical Structure of the Phospholipid Polymer on Fibronectin Adsorption and Fibroplast Adhesion on the Gradient Phospholipid Surface”, Biomaterials, 1999, pp. 2185-2191, vol. 20, Elsevier Science Ltd.
Rosentreter et al., Response of Retinal Ganglion Cell Axons to Striped Linear Gradients of Repellent Guidance Molecules, Journal of Neurobiology, 1998, pp. 541-562, vol. 37, John Wiley & Sons, Inc.
Halfter et al., “The Behavior of Optic Axons on Substrate Gradients of Retinal Basal Lamina Proteins and Merosin”, Journal of Neuroscience, Jul. 15, 1996, pp. 4389-4401, vol. 16, No. 14, Society of Neuroscience.
Zheng et al., Guidance of Regenerating Motor Axons In Vivo by Gradients of Diffusible Peripheral Nerve-Derived Factors, Journal of Neruobiology, 2000, pp. 212-279, vol. 42, John Wiley & Sons.
Binette Francois
Coleman Cynthia Marie
Kadiyala Sudhakar
Kapur Theresa Adams
DePuy Spine, Inc.
DiMauro Thomas M.
Kennedy Sharon
LandOfFree
Musculo-skeletal implant having a bioactive gradient does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Musculo-skeletal implant having a bioactive gradient, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Musculo-skeletal implant having a bioactive gradient will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2796549